Clinical Trials Logo

Clinical Trial Details — Status: Recruiting

Administrative data

NCT number NCT03723044
Other study ID # 38RC18.059
Secondary ID
Status Recruiting
Phase N/A
First received
Last updated
Start date June 5, 2020
Est. completion date May 2025

Study information

Verified date January 2024
Source University Hospital, Grenoble
Contact Anne Guerin, PhD
Phone 4 76 57 43 73
Email anne.guerin@gipsa-lab.grenoble-inp.fr
Is FDA regulated No
Health authority
Study type Interventional

Clinical Trial Summary

Some stimuli, such as sinusoidal networks in motion, or the best known, Necker's cube, are simple visual stimulations generating interpretations of unstable and oscillatory shapes or movements, mutually exclusive. Currently, the explanatory models of these perception phenomena are based on adaptation and learning mechanisms as well as the importance of noise in the perceptual and decision-making system. Often noise is a harmful component, but it can also be a facilitator in perceptual systems: the investigator's eye is always in motion, it is the micro-movements during eye fixation (phase of eye stability). In particular, the role of micro-eye movements has been identified in perceptual systems, and it will be necessary here to relate these micro-movements to the perceptive tilts facing multisable stimuli. However, how to access the perceptive states is a real question, since it has been shown that the participant's transfer of his perceptual state by means of a motor response can alter the very state of the percept. This is why the EEG activity will be analyzed to learn to discriminate the different percepts over time, without disruption of the participant's perceptual exploration endogenous activity.


Description:

Each participant will benefit from a medical interview before inclusion to eliminate the contraindications to this study. The maximum duration of the individual participation of each subject in this study is 5 hours in two sessions. Each session lasts 2h30. Both sessions are spaced a maximum of 14 days apart. Each session includes EEG headset placement and oculometer calibration (20 min), followed by recording EEG and eye tracking activity during a visual cognitive task where the participant will be presented with multi-stable visual stimuli to watch. for one or two minutes after the tests. By repeating the essays and the conditions of presentation, each session will be organized in six blocks of 20 minutes each, interspersed with a break.


Recruitment information / eligibility

Status Recruiting
Enrollment 80
Est. completion date May 2025
Est. primary completion date May 2025
Accepts healthy volunteers Accepts Healthy Volunteers
Gender All
Age group 18 Years to 55 Years
Eligibility Inclusion Criteria: - Signed informed consent - Medical examination carried out before the participation in the research - Age between 18 and 55 years - Minimum level of studies - Obligation to join the social security system - normal or corrected vision normal Exclusion Criteria: - Subject included in another clinical and / or therapeutic experimentation in progress - Major vision disorder - Past or current neurological or neuropsychiatric pathologies - History of cranial trauma with loss of consciousness. - Medication treatments likely to modulate brain activity: benzodiazepine, antidepressants, neuroleptics, lithium, etc. - Diabetes, cardiac pathology, immunodeficiency. - Medication treatments likely to modulate the activity of the cardiovascular system. - History of abuse or recent ingestion of alcohol, hard drugs or doping products. - Consumption of more than 15 cigarettes per day - Subject deprived of liberty by a judicial or administrative decision (L1121-6 CSP) - Major subject subject to a legal protection measure or unable to express their consent (L1121-8 CSP) - Pregnant, parturient and nursing mothers (L1121-5)

Study Design


Related Conditions & MeSH terms


Intervention

Other:
EEG and occulometry
Each participants will spend two sessions of EEG and occulometry during a visual cognitive task where she/her will be presented with multi-stable visual stimuli to gaze at for one or two minutes. Depending on the experimental conditions, the participant will provide or not her/his perceptual state (i.e. which stimulus has been perceived ).

Locations

Country Name City State
France CHU Grenoble-Alpes Grenoble

Sponsors (2)

Lead Sponsor Collaborator
University Hospital, Grenoble GIPSA-LAB

Country where clinical trial is conducted

France, 

Outcome

Type Measure Description Time frame Safety issue
Primary Micro-eye movement Eye movements will be recorded with an eye-tracker : the continuous gaze position at each sampling period (1ms) along the complete experiment (2 hours) per session and per participant.
Primary Electroencephalography EEG will be recorded with 64 scalp electrodes (sampling rate 1kHz) with alpha and gamma waveform to found synchronuous neural correlates with the peceptive changes. along the complete experiment (2 hours) per session and per participant.
See also
  Status Clinical Trial Phase
Completed NCT05067062 - Intake Duration Effects of Blackcurrant on Cardiovascular and Metabolic Responses N/A
Completed NCT05182138 - Zinc in Potatoes Study N/A
Completed NCT01256515 - Health Management Training to Enhance Influenza Vaccine Immunogenicity N/A
Recruiting NCT04659850 - Impact of AGEs on Metabolism & Cognition N/A
Recruiting NCT05624372 - Speech Perception in Noise in Children With ADHD
Completed NCT03399240 - Clinical Evaluation of the Accuracy of Vitastiq Device for Tracking Vitamin and Mineral Trend in Human Body N/A
Completed NCT05628753 - Lung Ultrasound as a Predictor for Successful Extubation in Preterm Infants
Recruiting NCT02116075 - Caudal Corticosteroid vs. Dextrose Injection for Lumbosacral Radicular Pain. Phase 2
Recruiting NCT04635410 - Improving Ultrasound Based Prediction of Delivery Mode
Completed NCT01294514 - Novel Non-Invasive Monitoring Parameter in Healthy Volunteers N/A
Completed NCT05042518 - Psychological Skill Training for Athletes N/A